Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Lianshui Pharmaceutical is a Chinese pharmaceutical manufacturer specializing in the production of large and small-volume parenterals, as well as solid oral dosage forms like tablets and capsules. Founded in 1970 and headquartered in Huai'an, Jiangsu Province, the company is a significant provider of essential medicines, including intravenous solutions such as Sodium Chloride and Glucose injections. Its product portfolio covers a wide range of therapeutic areas, including anti-infectives, cardiovascular treatments, and gastrointestinal medicine. Lianshui Pharmaceutical operates modern GMP-certified manufacturing facilities and primarily serves the domestic healthcare market in China through hospital and clinical distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lianshui Pharmaceutical.